Search
for
Sort by
Research 31–60 of 1000+
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Are the cutaneous manifestations during or due to SARS-CoV-2 infection/COVID-19 frequent or not? Revision of possible pathophysiologic mechanisms
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Immunoreactivity of the SARS-CoV-2 entry proteins ACE-2 and TMPRSS-2 in murine models of hormonal manipulation, ageing, and cardiac injury
- mRNA Levels of Aromatase, 5α-Reductase Isozymes, and Prostate Cancer-Related Genes in Plucked Hair from Young Men with Androgenic Alopecia
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Comment on “Androgens and women: COVID‐19 outcomes in women with acne vulgaris, polycystic ovarian syndrome, and hirsutism”
- Androgen receptor modulators: a review of recent patents and reports (2012-2018)
- COVID-19 pandemic: what about the gonads?
- Cardiac and Renal SARS-CoV-2 Viral Entry Protein Regulation by Androgens and Diet: Implications for Polycystic Ovary Syndrome and COVID-19
- Is COVID-19 Gender-sensitive?
- Analyzing the role of ACE2, AR, MX1 and TMPRSS2 genetic markers for COVID-19 severity
- The significance of coronavirus infection in the development of reproductive and lower urinary tract lesions
- Protective trend of anti-androgen therapy during the COVID-19 pandemic: A meta-analysis
- Alopecia areata and subsequent Marie Antoinette syndrome following COVID-19 infection and vaccination: A case report
- The Association between COVID-19 Infection and Gabrin Sign: A Case-Control Study
- Intratumoral <i>De Novo</i> Steroid Synthesis Activates Androgen Receptor in Castration-Resistant Prostate Cancer and Is Upregulated by Treatment with CYP17A1 Inhibitors
- The Rationale for Inhibiting 5α-Reductase Isoenzymes in the Prevention and Treatment of Prostate Cancer
- Skin manifestations associated with COVID-19
- Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
- Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19
- Trapa bispinosa Roxb. Pericarp Extract Exerts 5α-Reductase Inhibitory Activity in Castrated Benign Prostatic Hyperplasia Model Mice
- From bedside to bench: regulation of host factors in SARS-CoV-2 infection
- COVID-19 Can Exacerbate Pattern Hair Loss and Trigger Telogen Effluvium - The Role of Proteoglycan Replacement Therapy with Nourkrin® in Clinical Treatment of COVID-19 Associated Hair Loss
- SARS-CoV-2 Spike Protein S1-Mediated Endothelial Injury and Pro-Inflammatory State Is Amplified by Dihydrotestosterone and Prevented by Mineralocorticoid Antagonism
- Gender Differences in Response to COVID-19 Infection and Vaccination
- Antiandrogens as Therapies for COVID-19: A Systematic Review
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- COVID‐19, androgens, and androgenic alopecia
- Androgen deprivation therapy and hormonal status in men with COVID-19